🚀 Gate Square “Gate Fun Token Challenge” is Live!
Create tokens, engage, and earn — including trading fee rebates, graduation bonuses, and a $1,000 prize pool!
Join Now 👉 https://www.gate.com/campaigns/3145
💡 How to Participate:
1️⃣ Create Tokens: One-click token launch in [Square - Post]. Promote, grow your community, and earn rewards.
2️⃣ Engage: Post, like, comment, and share in token community to earn!
📦 Rewards Overview:
Creator Graduation Bonus: 50 GT
Trading Fee Rebate: The more trades, the more you earn
Token Creator Pool: Up to $50 USDT per user + $5 USDT for the first 50 launche
Citi: Initiate coverage on Shindah Biotech with a 'Buy' rating and a target price of HKD 55
Jinshi Data, November 5th, Citigroup released a research report stating that Sino Biopharmaceutical (01801.HK) announced the termination of the Fortvita subscription transaction. The company’s management stated at an investor conference on November 4th that the original intention of the transaction was to accelerate the development of the company’s overseas business, Fortvita. After the transaction was terminated, there is currently no further financing plan for Fortvita. Since the announcement of the transaction, the group’s stock price has fallen by more than 20%. Looking ahead, the bank believes that the group’s strong sales performance and overseas bed progress will sustainably restore investor confidence. Rating ‘buy’, target price of 55 Hong Kong dollars.